Phase 1/2 Study of AGN-241622 in Healthy Participants and Participants With Presbyopia
Public ClinicalTrials.gov record NCT04403763. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A First-in-Human, Phase 1/2, Dose-ascending, Multicenter, Masked, Randomized, Vehicle-controlled Study Evaluating the Safety, Tolerability, and Pharmacokinetics of AGN-241622 in Healthy Participants and Participants With Presbyopia (Stage 1 and Stage 2) and Efficacy in Participants With Presbyopia (Stage 2)
Study identification
- NCT ID
- NCT04403763
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 1, Phase 2
- Lead sponsor
- AbbVie
- Industry
- Enrollment
- 80 participants
Conditions and interventions
Conditions
Interventions
- AGN-241622 Drug
- Vehicle Drug
Drug
Eligibility (public fields only)
- Age range
- 40 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 26, 2020
- Primary completion
- Dec 4, 2022
- Completion
- Dec 4, 2022
- Last update posted
- Feb 5, 2024
2020 – 2022
United States locations
- U.S. sites
- 10
- U.S. states
- 6
- U.S. cities
- 10
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| United Medical Research Institute /ID# 234612 | Inglewood | California | 90301 | — |
| Global Research Foundation /ID# 237353 | Los Angeles | California | 90041-1718 | — |
| North Valley Eye Medical Group, Inc. /ID# 236686 | Mission Hills | California | 91345-1200 | — |
| The Eye Research Foundation /ID# 234526 | Newport Beach | California | 92663-3637 | — |
| Quantum Clinical Trials /ID# 237330 | Miami Beach | Florida | 33140 | — |
| Kannarr Eye Care /ID# 236718 | Pittsburg | Kansas | 66762-2620 | — |
| The Eye Care Institute /ID# 234507 | Louisville | Kentucky | 40206 | — |
| Total Eye Care, PA /ID# 234454 | Memphis | Tennessee | 38119-5745 | — |
| PPD Clinical Research Unit - Austin /ID# 237644 | Austin | Texas | 78744 | — |
| Eye associates /ID# 236502 | San Antonio | Texas | 78229 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04403763, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 5, 2024 · Synced Jul 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04403763 live on ClinicalTrials.gov.